66 related articles for article (PubMed ID: 20036351)
1. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival.
Colonna M; Bossard N; Guizard AV; Remontet L; Grosclaude P;
Ann Endocrinol (Paris); 2010 Mar; 71(2):95-101. PubMed ID: 20036351
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer in Luxembourg: a national population-based data report (1983-1999).
Scheiden R; Keipes M; Bock C; Dippel W; Kieffer N; Capesius C
BMC Cancer; 2006 Apr; 6():102. PubMed ID: 16635261
[TBL] [Abstract][Full Text] [Related]
3. Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa.
Santos JE; Kalk WJ; Freitas M; Marques Carreira I; Castelo Branco M
BMC Res Notes; 2015 Jul; 8():284. PubMed ID: 26126625
[TBL] [Abstract][Full Text] [Related]
4. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.
Kilfoy BA; Devesa SS; Ward MH; Zhang Y; Rosenberg PS; Holford TR; Anderson WF
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1092-100. PubMed ID: 19293311
[TBL] [Abstract][Full Text] [Related]
5. Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?
Oh CM; Lim J; Jung YS; Kim Y; Jung KW; Hong S; Won YJ
Cancer Med; 2021 Jun; 10(12):4087-4096. PubMed ID: 33979040
[TBL] [Abstract][Full Text] [Related]
6. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.
Aschebrook-Kilfoy B; Ward MH; Sabra MM; Devesa SS
Thyroid; 2011 Feb; 21(2):125-34. PubMed ID: 21186939
[TBL] [Abstract][Full Text] [Related]
7. Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies.
Kitahara CM; McCullough ML; Franceschi S; Rinaldi S; Wolk A; Neta G; Olov Adami H; Anderson K; Andreotti G; Beane Freeman LE; Bernstein L; Buring JE; Clavel-Chapelon F; De Roo LA; Gao YT; Gaziano JM; Giles GG; Håkansson N; Horn-Ross PL; Kirsh VA; Linet MS; MacInnis RJ; Orsini N; Park Y; Patel AV; Purdue MP; Riboli E; Robien K; Rohan T; Sandler DP; Schairer C; Schneider AB; Sesso HD; Shu XO; Singh PN; van den Brandt PA; Ward E; Weiderpass E; White E; Xiang YB; Zeleniuch-Jacquotte A; Zheng W; Hartge P; Berrington de González A
Thyroid; 2016 Feb; 26(2):306-18. PubMed ID: 26756356
[TBL] [Abstract][Full Text] [Related]
8. Rising incidence of thyroid cancer in Singapore not solely due to micropapillary subtype.
Shulin JH; Aizhen J; Kuo SM; Tan WB; Ngiam KY; Parameswaran R
Ann R Coll Surg Engl; 2018 Apr; 100(4):295-300. PubMed ID: 29543059
[TBL] [Abstract][Full Text] [Related]
9. Incidence and mortality trends of thyroid cancer from 1980 to 2016.
Wirth S; Syleouni ME; Karavasiloglou N; Rinaldi S; Korol D; Wanner M; Rohrmann S
Swiss Med Wkly; 2021 Oct; 151():w30029. PubMed ID: 34751539
[TBL] [Abstract][Full Text] [Related]
10. Exploring temporal trends and influencing factors for thyroid cancer in Guangzhou, China: 2004-2018.
Zhou J; Liang B; Liu Y; Wang S; Xu H; Li K; Liang H; Sun Z; Wang Y; Zhang J; Hu X; Qin P
Endocrine; 2024 May; 84(2):509-523. PubMed ID: 37936008
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence and histological pattern of thyroid cancer in Ho Chi Minh City, Vietnam (1996-2015): a population-based study.
Pham DX; Nguyen HD; Phung AHT; Bui TD; Tran TS; Tran BNH; Ho-Pham LT; Nguyen TV
BMC Cancer; 2021 Mar; 21(1):296. PubMed ID: 33743620
[TBL] [Abstract][Full Text] [Related]
12. Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986-2015: The impact of overdiagnosis.
Li M; Delafosse P; Meheus F; Borson-Chazot F; Lifante JC; Simon R; Groclaude P; Combes JD; Dal Maso L; Polazzi S; Duclos A; Colonna M; Vaccarella S;
Cancer Epidemiol; 2021 Dec; 75():102051. PubMed ID: 34743057
[TBL] [Abstract][Full Text] [Related]
13. International patterns and trends in thyroid cancer incidence, 1973-2002.
Kilfoy BA; Zheng T; Holford TR; Han X; Ward MH; Sjodin A; Zhang Y; Bai Y; Zhu C; Guo GL; Rothman N; Zhang Y
Cancer Causes Control; 2009 Jul; 20(5):525-31. PubMed ID: 19016336
[TBL] [Abstract][Full Text] [Related]
14. Thyroid cancer "epidemic" also occurs in low- and middle-income countries.
Lortet-Tieulent J; Franceschi S; Dal Maso L; Vaccarella S
Int J Cancer; 2019 May; 144(9):2082-2087. PubMed ID: 30242835
[TBL] [Abstract][Full Text] [Related]
15. Timely assessment of 5-year relative survival for patients with thyroid cancer from Taizhou, eastern China: a period analysis.
Huang J; Cao J; Zhang L; Fang M; Cheng Y; Lu DL; Wang L; Chen T
Eur J Cancer Prev; 2024 Jan; 33(1):62-68. PubMed ID: 37477151
[TBL] [Abstract][Full Text] [Related]
16. Early mortality critically impedes improvements in thyroid cancer survival through a half century.
Tichanek F; Försti A; Liska V; Hemminki O; Koskinen A; Hemminki A; Hemminki K
Eur J Endocrinol; 2023 Sep; 189(3):355-362. PubMed ID: 37675794
[TBL] [Abstract][Full Text] [Related]
17. The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases.
Li M; Meheus F; Polazzi S; Delafosse P; Borson-Chazot F; Seigneurin A; Simon R; Combes JD; Dal Maso L; Colonna M; Duclos A; Vaccarella S;
Value Health; 2023 Aug; 26(8):1175-1182. PubMed ID: 36921898
[TBL] [Abstract][Full Text] [Related]
18. [RETRAIT: Descriptive epidemiology of thyroid cancer in France: Incidence, mortality and survival.].
Colonna M; Bossard N; Guizard AV; Remontet L; Grosclaude P;
Ann Endocrinol (Paris); 2009 Dec; ():. PubMed ID: 20036352
[No Abstract] [Full Text] [Related]
19. Experiments on Temporary or Definitive Survivals Following Severe Hemorrhages.
War Med (Paris); 1919 Jan; 2(6):1071-1072. PubMed ID: 37757168
[No Abstract] [Full Text] [Related]
20. Overall survival of patients with thyroid cancer in Martinique (2008-2018).
Lin L; Almont T; Beaubrun M; Macni J; Pierre-Louis A; Zabulon A; Draganescu C; Lin L; Sabbah N; Drame M; Veronique-Baudin J; Joachim C
BMC Cancer; 2023 Aug; 23(1):739. PubMed ID: 37563603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
